What You Should Know:
- Heart failure is a critical health issue affecting millions of Americans, and despite decades of research, effective treatment options remain limited. Traditional drug development is a slow, costly, and high-risk process.
- Researchers at Mayo Clinic are pioneering a new approach using artificial intelligence (AI) and "virtual clinical trials" to accelerate the discovery of new therapies, particularly by repurposing existing drugs.
An Urgent Need for
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Inato Unveils AI Capabilities to Transform Clinical Trial Site Selection
What You Should Know:
- Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and verified data from over 5,500 sites quickly and easily.
- The new capabilities fill an acute gap for sponsor decision-makers, arming them with the insights they need to quickly and confidently choose the right mix of sites for each trial.
Inato Unveils
Read More
Proscia Launches AI Solution to Advance Precision Medicine
What You Should Know:
- Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
- The AI-powered tool aims to tackle one of healthcare’s most significant challenges: connecting patients with life-saving therapies and accelerating the development of new treatments.
Transforming Pathology Data Into Real-Time
Read More
Veeva Systems and Amgen Partner to Advance Clinical Trial Innovation
What You Should Know:
- Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
- Amgen will use the Veeva Clinical Platform to find and implement efficiencies across its clinical trial processes.
Connected Platform for Clinical Development
The Veeva Clinical Platform is a complete and connected platform that covers clinical operations and data applications. This end-to-end platform includes
Read More
Rimidi Partners with Beth Israel Deaconess Medical Center on Food as Medicine Trial
What You Should Know:
- Rimidi, a digital health company that supports healthcare providers with EHR-integrated software and connected devices, has announced its participation in the Health Care by Food (GoFreshSoutheast) Trial. The trial is managed by Beth Israel Deaconess Medical Center (BIDMC) and funded by The American Heart Association.
- The goal of the trial is to evaluate the impact of DASH-aligned grocery store delivery in reducing high blood pressure in adults.
- The
Read More
Cleveland Clinic and Dyania Health Partner to Accelerate Clinical Trial Recruitment with AI
What You Should Know:
- Cleveland Clinic and Dyania Health have announced a collaboration to integrate Dyania's Synapsis™ AI platform across Cleveland Clinic’s clinical research enterprise.
- The partnership, which follows successful pilot programs in cardiology, oncology, and neurology, aims to accelerate clinical trial recruitment by using medically trained large language models (LLMs) to speed up and scale patient identification for research studies. The ultimate goal is to provide more
Read More
Virtual Patients: How AI Simulation Is Revolutionizing Clinical Trials and Drug Development
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked by high costs, inefficiency, and human trial-and-error. Indeed, the cost of developing a single therapeutic exceeds $2.6 billion according to the Tufts Center for the Study of Drug Development. Much of this expense can be attributed to the clinical trial process.
Clinical trials are a
Read More
New Vivalink Survey Finds Nearly 90% of Americans Open to Remote Clinical Trials
What You Should Know:
- A new survey shows that remote clinical trials are not just a convenient option but a key factor in whether people choose to participate in research at all.
- The survey, conducted by digital healthcare solutions provider Vivalink, found that nearly 90% of Americans are open to participating in fully remote trials, signaling a major shift in patient expectations.
A Clear Preference for Virtual Trials
The survey, which polled over 200 U.S. adults,
Read More
How Sensor Technology Is Transforming Clinical Trials
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites, and sponsors, particularly in neurological disease trials, where phase III trials cost up to $370 million, last 7.9 years, and face a 95% failure rate among drug candidates 1,2,3. Moreover, traditional site-based data collection methods do not capture the complete picture of how patients are affected by
Read More
Unlocking the Power of Genomics in Clinical Trials: A Precision Medicine Data Imperative
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics and biomarker-based insights. These trials not only test therapeutic efficacy but also help identify which patients are most likely to benefit, reducing trial-and-error in treatment and transforming hope into more predictable outcomes. With nearly half a million clinical trials underway globally, the potential to
Read More
